Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations

References

• Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited diseases. New York: McGraw-Hill; 1995. pp 2103–60.
   Google Scholar
• Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998;18:67–75.
   PubMed Web of Science ®Google Scholar
• Mascaro JM. The porphyrias: a brief overview based on 25 years of experience (1969-1994) by the Department of Dermatology of the Hospital Clinic and Faculty of Medicine of Barcelona, Spain. J Dermatol 1995;22:823–8.
   PubMedGoogle Scholar
• Bygum A, Christiansen L, Petersen NE, Horder M, Thomsen K, Brandrup F. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status. Acta Derm Venereol 2003;83:115–20.
   PubMedGoogle Scholar
• Cruz-Rojo J, Fontanellas A, Moran-Jimenez MJ, Navarro-Ordonez S, Garcia-Bravo M, Mendez M, et al. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol 2002;48:845–52.
   Google Scholar
• Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda [see comments]. Lancet 1997;349 (9048):321–3.
   Google Scholar
• Lamoril J, Andant C, Gouya L, Malonova E, Grandchamp B, Martasek P, et al. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT). Cell Mol Biol 2002;48:33–41.
   PubMedGoogle Scholar
• Romana M, Dubart A, Beaupain D, Chabret C, Goossens M, Romeo PH. Structure of the gene for human uroporphyrinogen decarboxylase. Nucleic Acids Res 1987;15:7343–56.
   PubMed Web of Science ®Google Scholar
• Moran-Jimenez MJ, Ged C, Romana M, Enriquez DS, Taieb A, Topi G, et al. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythro-poietic porphyria. Am J Hum Genet 1996;58:712–21.
   Google Scholar
• Christiansen L, Ged C, Hombrados I, Brons-Poulsen J, Fontanellas A, de Verneuil H, et al. Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT. Hum Mutat 1999;14:222–32.
   Google Scholar
• Phillips JD, Parker TL, Schubert HL, Whitby FG, Hill CP, Kushner JP. Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase. Blood 2001;98:3179–85.
   PubMedGoogle Scholar
• Cappellini MD, Martinez DM, Tavazzi D, Fargion S, Pizzuti A, Comino A, et al. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT). Hum Mutat 2001;17:350.
   PubMedGoogle Scholar
• Garey JR, Harrison LM, Franklin KF, Metcalf KM, Radisky ES, Kushner JP. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. J Chin Invest 1990;86:1416–22.
   PubMedGoogle Scholar
• McManus JF, Begley CG, Sassa S, Ratnaike S. Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria. Blood 1996;88:3589–600.
   PubMed Web of Science ®Google Scholar
• Meguro K, Fujita H, Ishida N, Akagi R, Kurihara T, Galbraith RA, et al. Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria. J Invest Dermatol 1994;102:681–5.
   PubMed Web of Science ®Google Scholar
• Phillips JD, Whitby FG, Kushner JP, Hill CP. Characterization and crystallization of human uroporphyrinogen decarboxylase. Protein Sci 1997;6:1343–6.
   PubMedGoogle Scholar
• Whitby FG, Phillips JD, Kushner JP, Hill CP. Crystal structure of human uroporphyrinogen decarboxylase. EMBO J 1998;17:2463–71.
   PubMed Web of Science ®Google Scholar
• Christiansen L, Bygum A, Jensen A, Brandrup F, Thomsen K, Horder M, et al. Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda. Scand J Chin Lab Invest 2000;60:611–5.
   PubMedGoogle Scholar
• Brons-Poulsen J, Petersen NE, Horder M, Kristiansen K. An improved PCR-based method for site directed mutagenesis using megaprimers. Mol Cell Probes 1998;12:345–8.
   Google Scholar
• Marczinovits I, Somogyi C, Patthy A, Nemeth P, Molnar J. An alternative purification protocol for producing hepatitis B virus X antigen on a preparative scale in Escherichia coli. J Biotechnol 1997;56:81–8.
   Google Scholar
• Wan M, Takagi M, Loh BN, Imanaka T. Comparison of HIV-1 protease expression in different fusion forms. Biochem Mol Biol hit 1995;36:411–9.
   PubMedGoogle Scholar
• de Carlos A, Montenegro D, Alonso-Rodriguez A, Paez d1C, Rodriguez-Berrocal FJ, Martinez-Zorzano VS. Purification of human alpha-L-fucosidase precursor expressed in Escherichia coli as a glutathione S-transferase fusion protein. J Chromatogr B Analyt Technol Biomed Life Sci 2003;786:7–15.
   Google Scholar
• de Verneuil H, Sassa S, Kappas A. Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III. J Biol Chem 1983;258:2454–60.
   Google Scholar
• Sassa S, de Verneuil H, Anderson KE, Kappas A. Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tarda. Trans Assoc Am Phys 1983;96:65–75.
   PubMedGoogle Scholar
• Roberts AG, Elder GH. Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. Methods Enzymol 1997;281:349–55.
   PubMedGoogle Scholar
• de Verneuil H, Grandchamp B, Nordmann Y. Some kinetic properties of human red cell uroporphyrinogen decarboxylase. Biochim Biophys Acta 1980;611:174–86.
   PubMed Web of Science ®Google Scholar
• Mukerji SK, Pimstone NR. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda. Biochem Biophys Res Commun 1985;127:517–25.
   PubMedGoogle Scholar
• Wyckoff EE, Phillips JD, Sowa AM, Franklin MR, Kushner JP. Mutational analysis of human uroporphyrinogen decarboxylase. Biochim Biophys Acta 1996;1298:294–304.
   PubMedGoogle Scholar
• Wagner E, Lykke-Andersen J. mRNA surveillance: the perfect persist. J Cell Sci 2002;115:3033–8.
   PubMed Web of Science ®Google Scholar